Clinically high-risk breast cancer displays markedly discordant molecular risk predictions between the MammaPrint and EndoPredict tests.Tools Jahn, Stephan Wenzel, Bösl, Andreas, Tsybrovskyy, Oleksiy, Gruber-Rossipal, Christine, Helfgott, Ruth, Fitzal, Florian, Knauer, Michael, Balic, Marija, Jasarevic, Zerina, Offner, Felix and Moinfar, Farid (2020) Clinically high-risk breast cancer displays markedly discordant molecular risk predictions between the MammaPrint and EndoPredict tests. British journal of cancer, 122 (12). pp. 1744-1746. ISSN 1532-1827 Full text not available from this repository.
|
||||||||||||||||
|
|
|
|
Tools
Tools